NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Часто задаваемые вопросы
В каком секторе работает NexGel Inc Warrant (NXGLW)?
NexGel Inc Warrant относится к сектору Здравоохранение.
Какова текущая цена акций NexGel Inc Warrant (NXGLW)?
По последним данным, цена акций NexGel Inc Warrant составляет 0,01 $, предыдущее закрытие — 0,01 $.
Выплачивает ли NexGel Inc Warrant (NXGLW) дивиденды?
Нет, NexGel Inc Warrant не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у NexGel Inc Warrant (NXGLW)?
У компании NexGel Inc Warrant бета 0.622, что указывает на более низкую волатильность по сравнению с рынком в целом.
